Condition: PsA (Psoriatic Arthritis) · Sponsor: InventisBio Co., Ltd
This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial. The target population is patients with active psoriatic arthritis. A total of 222 subjects are planned to be included.
This description comes directly from the study's public registry record.
yi liu, Dr. · 13401466347 · zhongchen.ma@inventisbio.com
chen zhong ma · 13401466347 · zhongchen.ma@inventisbio.com
Always discuss trial participation with your own doctor first.
| West China School of Medicine | Chengdu, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07315061